Biotech

All Articles

Atea's COVID antiviral neglects to stop hospital stays in period 3

.Atea Pharmaceuticals' antiviral has actually neglected one more COVID-19 trial, yet the biotech sti...

Neurocrine's proposal to spare mental illness possibility falls short

.Neurocrine Biosciences' mental illness plan pivot has fallen short. The biotech was actually not ab...

Sanofi spends $110M upfront for late-stage radioligand therapy

.Sanofi has created an overdue entrance to the radioligand event, paying for 100 thousand europeans ...

F 2G increases $100M for 2nd try to receive brand new antifungal to market

.After F2G's 1st attempt to receive a brand-new course of antifungal to market was hindered by the F...

Moderna targets $1.1 B in R&ampD spending slices, drops 5 plans amidst profits tensions

.Moderna has actually vowed to cut R&ampD costs through $1.1 billion through 2027. The decision to s...

Sanofi's $80M bet on Key dystrophy drug finishes in period 3 go bust

.Only 4 months after Sanofi bet $80 thousand in ahead of time cash on Pivot Therapies' losmapimod, t...

Oncternal stock drains 60% surrounded by layoffs, trial firings

.Cancer firm Oncternal Rehabs is actually folding all its medical tests and also giving up personnel...

Roche is actually supporting out hopes that its own injectable obesity possibility might inevitably demonstrate 25% weight management in late-stage trial

.Roche is storing out chances that its injectable obesity possibility might ultimately display 25% w...

Novo Nordisk hails 'impressive' fat loss result for dual-acting oral medicine in very early trial

.Novo Nordisk has actually raised the cover on a phase 1 test of its own dental amylin and also GLP-...

AbbVie sues BeiGene over blood cancer medication classified information

.Only a couple of quick weeks after winning an FDA Fast lane tag for its own investigational BTK deg...